Matteo S. Carlino, Emily Roberts-Thomson, Glenn C. Michelson, Alain Patrick Algazi, Igor Puzanov, Kevin Joseph Harrington, Tanguy Y. Seiwert, Peter Haberz, Ravindra Gujar, Chang Cui, Lev Becker. "OP-NEU-101: A phase 1/2 open-label, dose finding and expansion study to investigate the safety and effectiveness and determine the optimal dose of N17350 administered intratumorally in participants with advanced solid tumors.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps2679